↓ Skip to main content

New trends in cancer for the 21st century

Overview of attention for book
Cover of 'New trends in cancer for the 21st century'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS)
  3. Altmetric Badge
    Chapter 2 Targeted Therapies in Ewing's Sarcoma
  4. Altmetric Badge
    Chapter 3 The CCN3 protein and cancer.
  5. Altmetric Badge
    Chapter 4 EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
  6. Altmetric Badge
    Chapter 5 Molecular Karyotyping in Sarcoma Diagnostics and Research
  7. Altmetric Badge
    Chapter 6 TuBaFrost: European Virtual Tumor Tissue Banking
  8. Altmetric Badge
    Chapter 7 Virtual Microscopy in Virtual Tumor Banking
  9. Altmetric Badge
    Chapter 8 Harmonizing Cancer Control in Europe
  10. Altmetric Badge
    Chapter 9 The Diagnosis of Cancer: “From H&E to Molecular Diagnosis and Back“
  11. Altmetric Badge
    Chapter 10 From Morphological to Molecular Diagnosis of Soft Tissue Tumors
  12. Altmetric Badge
    Chapter 11 Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract
  13. Altmetric Badge
    Chapter 12 Integrating the Diagnosis of Childhood Malignancies
  14. Altmetric Badge
    Chapter 13 Preclinical Models for Cell Cycle-Targeted Therapies
  15. Altmetric Badge
    Chapter 14 WWOX, a chromosomal fragile site gene and its role in cancer.
  16. Altmetric Badge
    Chapter 15 From Genome to Proteome in Tumor Profiling: Molecular Events in Colorectal Cancer Genesis
  17. Altmetric Badge
    Chapter 16 Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma and Breast Cancer Models
  18. Altmetric Badge
    Chapter 17 Methylation patterns and chemosensitivity in NSCLC.
  19. Altmetric Badge
    Chapter 18 Pharmacogenomics and Colorectal Cancer
  20. Altmetric Badge
    Chapter 19 Development of pharmacogenomic predictors for preoperative chemotherapy of breast cancer.
  21. Altmetric Badge
    Chapter 20 Vascular Endothelial Growth Factor Inhibitors in Colon Cancer
  22. Altmetric Badge
    Chapter 21 Molecular Imaging of Cancer Using PET and SPECT
  23. Altmetric Badge
    Chapter 22 MRS as Endogenous Molecular Imaging for Brain and Prostate Tumors: FP6 Project “eTUMOR“
  24. Altmetric Badge
    Chapter 23 From Linac to Tomotherapy: New Possibilities for Cure?
  25. Altmetric Badge
    Chapter 24 Targeting mTOR for Cancer Treatment
  26. Altmetric Badge
    Chapter 25 Dual/pan-HER tyrosine kinase inhibitors: focus in breast cancer.
  27. Altmetric Badge
    Chapter 26 AntiTumor-Associated Antigens IGGS: Dual Positive and Negative Potential Effects for Cancer Therapy
  28. Altmetric Badge
    Chapter 27 Synergistic molecular mechanisms in hormone-sensitive breast cancer.
Attention for Chapter 4: EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
Chapter number 4
Book title
New trends in cancer for the 21st century
Published in
Advances in experimental medicine and biology, December 2006
DOI 10.1007/978-1-4020-5133-3_4
Pubmed ID
Book ISBNs
978-1-4020-4966-8, 978-1-4020-5133-3
Authors

Ban J, Siligan C, Kreppel M, Aryee D, Kovar H, Ban, J., Siligan, C., Kreppel, M., Aryee, D., Kovar, H.

Abstract

Ewing's sarcoma family of tumors (ESFT) are a clinically and scientifically very demanding group of tumors in children and young adults with still unknown histogenesis. The rate-limiting oncogenic mutation in this disease has been identified as a chromosomal translocation, t(11;22)(q24;q12), that leads to the expression of a chimeric transcription factor, EWS-FLI1. We have studied the downstream pathway of EWS-FLI1 by a dual strategy including the isolation of direct target genes from ESFT chromatin and the monitoring of transcriptomic changes after silencing of EWS-FLI1 by RNA interference. This study has lead to the identification of several directly EWS-FLI1-regulated genes and the characterization of their genomic distribution. By comparing several ESFT cell lines, not only variation in overall gene expression patterns downstream of EWS-FLIl was observed, but also differential regulation of directly EWS-FLI1-bound genes. Interestingly, there was variation between members of the same functional gene families. Studies on CD99, another diagnostic hallmark of ESFT, in relation to EWS-FLI1 provided additional evidence for context dependence of fusion protein function. Together, our study represents a first approach to the separation of essential molecular consequences from noise generated by the EWS-FLI1 gene rearrangement in ESFT.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 8%
Unknown 12 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 23%
Student > Master 2 15%
Student > Doctoral Student 1 8%
Student > Bachelor 1 8%
Student > Ph. D. Student 1 8%
Other 3 23%
Unknown 2 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 31%
Biochemistry, Genetics and Molecular Biology 3 23%
Medicine and Dentistry 2 15%
Social Sciences 1 8%
Engineering 1 8%
Other 0 0%
Unknown 2 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2007.
All research outputs
#7,454,066
of 22,788,370 outputs
Outputs from Advances in experimental medicine and biology
#1,227
of 4,933 outputs
Outputs of similar age
#41,771
of 156,351 outputs
Outputs of similar age from Advances in experimental medicine and biology
#19
of 47 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,933 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,351 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.